EGFR and hepatocellular carcinoma: As ligand concentrations and kinetics were the same, such discrepancy may be attributable to the use of different cellular models, namely an EGFR‐null clone of murine NIH/3T3 fibroblasts stably transfected with plasmids expressing chimeric receptors, compared to unmodified human HCC cell lines.